Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

被引：0
|
作者：
Xavière Panhard
Mayeule Legrand
Anne-Marie Taburet
Bertrand Diquet
Cécile Goujard
France Mentré
机构：
[1] INSERM U738,INSERM U738; UF de Biostatistiques
[2] AP-HP,UFR de Médecine
[3] Hôpital Bichat,Département de Pharmacologie Clinique
[4] Université Paris 7 Denis Diderot,Service de Pharmacie Clinique
[5] AP-HP,Service de Pharmacologie Clinique et Toxicologie
[6] Hôpital La Pitié-Salpétrière,Service de Médecine Interne
[7] AP-HP,undefined
[8] Hôpital Bicêtre,undefined
[9] CHU ANGERS,undefined
[10] AP-HP,undefined
[11] Hôpital Bicêtre,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Nucleoside analogs; Drug-drug interactions; Population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1019 / 1029
页数：10
相关论文
共 50 条
  • [31] Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients
    Lopez Aspiroz, Elena
    Santos Buelga, Dolores
    Cabrera Figueroa, Salvador Enrique
    Valverde Merino, Maria de la Paz
    Cordero Sanchez, Miguel
    Dominguez-Gil Hurle, Alfonso
    Carracedo, Angel
    Garcia Sanchez, Maria Jose
    [J]. PERSONALIZED MEDICINE, 2014, 11 (07) : 693 - 704
  • [32] Causes of macrocytosis in HIV-infected patients not treated with zidovudine
    Genné, D
    Sudre, P
    Anwar, D
    Goehring, C
    Saaïdia, A
    Hirschel, B
    [J]. JOURNAL OF INFECTION, 2000, 40 (02) : 160 - 163
  • [33] CONSENT TO TREATMENT WITH ZIDOVUDINE AMONG HIV-INFECTED PATIENTS
    LAI, KK
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 1992, 59 (01) : 45 - 47
  • [34] Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children
    Capparelli, EV
    Englund, JA
    Connor, JD
    Spector, SA
    McKinney, RE
    Palumbo, P
    Baker, CJ
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (02): : 133 - 140
  • [35] Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects
    Mario González-Sales
    Olivier Barrière
    Pierre Olivier Tremblay
    Fahima Nekka
    Jean-Claude Mamputu
    Sylvie Boudreault
    Mario Tanguay
    [J]. Clinical Pharmacokinetics, 2015, 54 : 285 - 294
  • [36] THE EFFECT OF ACETAMINOPHEN ON ZIDOVUDINE METABOLISM IN HIV-INFECTED PATIENTS
    STEFFE, EM
    KING, JH
    INCIARDI, JF
    FLYNN, NF
    GOLDSTEIN, E
    TONJES, TS
    BENET, LZ
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (07): : 691 - 694
  • [37] CYTOMEGALOVIRUS VIREMIA IN HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE
    SEGONDY, M
    ATOUI, N
    REYNES, J
    VENDRELL, JP
    DUCOS, J
    BLANC, P
    MANDIN, J
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1990, 22 (06) : 653 - 657
  • [38] ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED PATIENTS AND SERONEGATIVE VOLUNTEERS
    BARRY, M
    WILD, M
    VEAL, G
    BACK, D
    BRECKENRIDGE, A
    FOX, R
    BEECHING, N
    NYE, F
    CAREY, P
    TIMMINS, D
    [J]. AIDS, 1994, 8 (08) : F1 - F5
  • [39] Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons
    Fletcher, CV
    Kawle, SP
    Kakuda, TN
    Anderson, PL
    Weller, D
    Bushman, LR
    Brundage, RC
    Remmel, RP
    [J]. AIDS, 2000, 14 (14) : 2137 - 2144
  • [40] Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
    Anderson, Peter L.
    Lamba, Jatinder
    Aquilante, Christina L.
    Schuetz, Erin
    Fletcher, Courtney V.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (04) : 441 - 449
12345